Mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (melas) in the older adult

Practical Neurology

Volumn 14, Issue 6, 2014, Pages 432-436

  Aurangzeb, Sidra ^a   Vale, Thomas ^a   Tofaris, George ^b   Poulton, Joanna ^b   Turner, Martin R ^b  

^a OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; BRAIN; CASE REPORT; COMPLICATION; FEMALE; GENETICS; HUMAN; MELAS SYNDROME; ONSET AGE; PATHOLOGY;

AGE OF ONSET; AGED; BRAIN; FEMALE; HUMANS; MELAS SYNDROME;

EID: 84924812422     PISSN: 14747758     EISSN: 14747766     Source Type: Journal    
DOI: 10.1136/practneurol-2014-000853     Document Type: Article

References (36)

1. Vanniarajan A, Nayak D, Reddy AG, et al. Clinical and genetic uniqueness in an individual with MELAS. Am J Med Genet B Neuropsychiatr Genet 2006;141B:440–4.
2. Majamaa K, Moilanen JS, Uimonen S, et al. Epidemiology of A3243G, the mutation for mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes: prevalence of the mutation in an adult population. Am J Hum Genet 1998;63:447–54.
3. Manwaring N, Jones MM, Wang JJ, et al. Population prevalence of the MELAS A3243G mutation. Mitochondrion 2007;7:230–3.
4. Nesbitt V, Pitceathly RD, Turnbull DM, et al. The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A-G mutation— implications for diagnosis and management. J Neurol Neurosurg Psychiatry 2013;84:936–8.
5. Brown MD, Sun F, Wallace DC. Clustering of Caucasian Leber hereditary optic neuropathy patients containing the 11778 or 14484 mutations on an mtDNA lineage. Am J Hum Genet 1997;60:381–7.
6. Morten KJ, Poulton J, Sykes B. Multiple independent occurrence of the 3243 mutation in mitochondrial tRNA (leuUUR) in patients with the MELAS phenotype. Hum Mol Genet 1995;4:1689–91.
7. Jeppesen TD, Schwartz M, Frederiksen AL, et al. Muscle phenotype and mutation load in 51 persons with the 3243A-G mitochondrial DNA mutation. Arch Neurol 2006;63:1701–6.
8. Poulton J, Morten K. Noninvasive diagnosis of the MELAS syndrome from blood DNA. Ann Neurol 1993;34:116.
9. Rahman S, Poulton J, Marchington D, et al. Decrease of 3243 A-G mtDNA mutation from blood in MELAS syndrome: a longitudinal study. Am J Hum Genet 2001;68:238–40.
10. Rajasimha HK, Chinnery PF, Samuels DC. Selection against pathogenic mtDNA mutations in a stem cell population leads to the loss of the 3243A-G mutation in blood. Am J Hum Genet 2008;82:333–43.
11. McDonnell MT, Schaefer AM, Blakely EL, et al. Noninvasive diagnosis of the 3243A-G mitochondrial DNA mutation using urinary epithelial cells. Eur J Hum Genet 2004;12:778–81.
12. Hirano M, Pavlakis SG. Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes (MELAS): current concepts. J Child Neurol 1994;9:4–13.
13. Castillo M, Kwock L, Green C. MELAS syndrome: imaging and proton MR spectroscopic findings. AJNR Am J Neuroradiol 1995:16:233–9.
14. Kisanuki YY, Gruis KL, Smith TL, et al. Late-onset mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes with bitemporal lesions. Arch Neurol 2006;63:1200–1.
15. Majamaa K, Turkka J, Kärppä M, et al. The common MELAS mutation A3243G in mitochondrial DNA among young patients with an occipital brain infarct. Neurology 1997;49:1331–4.
16. Kimata KG, Gordan L, Ajax ET, et al. A Case of Late-Onset MELAS. Arch Neurol 1998;55:722–5.
17. Sharfstein SR, Gordon MF, Libman RB, et al. Adult-onset MELAS presenting as herpes encephalitis. Arch Neurol 1999;56:241–3.
18. Tzoulis C, Bindoff LA. Acute mitochondrial encephalopathy reflects neuronal energy failure irrespective of which genome the genetic defect affects. Brain 2012;135(Pt 12):3627–34.
19. Folbergrová J, Kunz WS. Mitochondrial dysfunction in epilepsy. Mitochondrion 2012;12:35–40.
20. de Toledo M, Díaz-Guzmán J, Pérez-Martínez DA, et al. MELAS syndrome masquerading as herpes encephalitis: genetic diagnosis. Rev Neurol 2001;33:148–50.
21. Johns DR, Stein AG, Wityk R. MELAS syndrome masquerading as herpes simplex encephalitis. Neurology 1993;43:2471–3.
22. Goodfellow JA, Dani K, Stewart W, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people. Postgrad Med J 2012;88:326–34.
23. Luis PB, Ruiter JP, Aires CC, et al. Valproic acid metabolites inhibit dihydrolipoyl dehydrogenase activity leading to impaired 2-oxoglutarate-driven oxidative phosphorylation. Biochim Biophys Acta 2007;1767:1126–33.
24. Lam CW, Lau CH, Williams JC, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS) triggered by valproate therapy. Eur J Pediatr 1997;156:562–4.
25. Jones DL, Greenaway TM. Beware the thin, deaf ‘type 2’ diabetic: maternally inherited diabetes and deafness with systemic (mitochondrial) manifestations. Intern Med J2004;34:517-8.
26. Kaufmann P, Engelstad K, Wei Y, et al.Natural history of MELAS associated with mitochondrial DNA m.3243A>G genotype. Neurology2011;77:1965-71.
27. Majamaa-Voltti KA, Winqvist S, Remes AM, et al.A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA. Neurology2006;66:1470-5.
28. Kaufmann P, Engelstad K, Wei Y, et al.Dichloroacetate causes toxic neuropathy in MELAS: a randomized, controlled clinical trial. Neurology2006;66:324-30.
29. Pfeffer G, Majamaa K, Turnbull DM, et al.Treatment for mitochondrial disorders. Cochrane Database Syst Rev2012;(4): CD004426.
30. Del Vecchio MA, Matika GL, Bav CA. Genetic counseling for mitochondrial disorders. Genet Med 2000;2:100.
31. Ciafaloni E, Ricci E, Shanske S, et al.MELAS: clinical features, biochemistry, and molecular genetics. Ann Neurol1992;31:391-8.
32. Vrettou CS, Zervakis D, Priovolos A, et al.MELAS syndrome diagnosed in ICU in a 56-year-old patient presenting with status epilepticus. Intensive Care Med2013;39:1148-9.
33. Hanna MG, Nelson IP, Morgan-Hughes JA, et al.MELAS: a new disease associated mitochondrial DNA mutation and evidence for further genetic heterogeneity. J Neurol Neurosurg Psychiatry1998;65:512-17.
34. Shanske S, Coku J, Lu J, et al.The G13513A mutation in the ND5 gene of mitochondrial DNA as a common cause of MELAS or Leigh syndrome: evidence from 12 cases. Arch Neurol2008;65:368-72.
35. Minamoto H, Kawabata K, Okuda B, et al.Mitochondrial encephalomyopathy with elderly onset of stroke-like episodes. Intern Med1996;35:991-5.
36. Leff AP, McNabb AW, Hanna MG, et al.Complex Partial Status Epilepticus in Late-Onset MELAS. Epilepsia1998;39:438-41.